1. Home
  2. JAGX vs ORIS Comparison

JAGX vs ORIS Comparison

Compare JAGX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.18

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$0.11

Market Cap

4.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
ORIS
Founded
2013
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
4.6M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
JAGX
ORIS
Price
$1.18
$0.11
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
380.3K
2.1M
Earning Date
11-17-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$11,785,000.00
$12,317,000.00
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
$510.25
Revenue Growth
12.45
N/A
52 Week Low
$1.00
$0.08
52 Week High
$33.25
$2.85

Technical Indicators

Market Signals
Indicator
JAGX
ORIS
Relative Strength Index (RSI) 41.39 39.78
Support Level $1.05 $0.11
Resistance Level $1.36 $0.13
Average True Range (ATR) 0.16 0.01
MACD 0.04 0.00
Stochastic Oscillator 38.00 16.02

Price Performance

Historical Comparison
JAGX
ORIS

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: